Key result
UCP1 -3826 G/G genotype linked to ~250% higher diabetic retinopathy risk in type 1 diabetes.
Why the study?
Deleterious polymorphisms in the UCP1 gene are candidate risk factors for diabetic retinopathy due to their role in mitochondrial ROS production.
Is the UCP1 -3826A/G polymorphism associated with diabetic retinopathy and altered UCP1/MnSOD2 gene expression in human retina?
Case-Control (n=364)
Is the UCP1 -3826A/G polymorphism associated with diabetic retinopathy and altered UCP1/MnSOD2 gene expression in human retina?
Odds Ratio: 3.503
p-value: p=0.043
The UCP1 -3826A/G polymorphism is associated with an increased risk of diabetic retinopathy in type 1 diabetes and influences UCP1 and MnSOD2 gene expression in the human retina.
UCP1 -3826 G/G may aid retinopathy risk stratification in type 1 diabetes; leaves open validation before clinical adoption.
PURPOSE: Uncoupling protein 1 (UCP1) reduces mitochondrial production of reactive oxygen species (ROS). ROS overproduction is related to diabetic retinopathy (DR), a chronic complication of diabetes mellitus (DM). Therefore, deleterious polymorphisms in the UCP1 gene are candidate risk factors for DR. We investigated the relationships between the UCP1 -3826A/G polymorphism and risk of DR and UCP1 gene expression in human retina. Considering that superoxide dismutase-2 (MnSOD2) enzyme is the first line of defense against oxidative stress in mitochondria, we also analyzed MnSOD2 gene expression in retinal samples according to different UCP1 -3826A/G genotypes. METHODS: In a case-control study, frequencies of -3826A/G polymorphisms were analyzed in 257 type 1 DM patients (154 cases with DR and 103 controls without DR). In a cross-sectional study comprising cadaveric cornea donors, UCP1 and MnSOD2 gene expressions were evaluated in 107 retinal samples differentiated according to different -3826A/G genotypes. RESULTS: In the type 1 DM group, multivariate analysis confirmed that the G/G genotype was an independent risk factor for DR (OR = 3.503; P = 0.043). In cornea donors, G allele carriers had higher UCP1 cDNA and protein concentrations than A/A carriers (P = 0.034 and P = 0.039, respectively). Interestingly, G allele carriers exhibited increased MnSOD2 expression (P = 0.001). CONCLUSIONS: This study suggests that the -3826A/G polymorphism is associated with DR in type 1 DM patients. This is the first report demonstrating UCP1 gene expression in human retinas and indicates that the -3826A/G polymorphism influences its expression. In addition, the -3826G allele was associated with increased MnSOD2 expression; thus, suggesting that this allele could be a marker of oxidative stress.
No takes yet. Share an insight, caveat, or question.
Brondani et al. (2012) conducted a case-control in Diabetic retinopathy in type 1 diabetes mellitus (n=364). UCP1 -3826A/G polymorphism vs. Other genotypes was evaluated on Diabetic retinopathy (OR 3.503, p=0.043). The UCP1 -3826 G/G genotype was an independent risk factor for diabetic retinopathy in type 1 diabetes patients (OR 3.503; P=0.043).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: